Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa
Subscribe To Our Newsletter & Stay Updated
